By continuing to use Symptoma®, you confirm you accept the cookies. More on
501101 to 501200 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Glossopharyngeal neuralgia and MS.
Glossopharyngeal neuralgia and ossification of the stylohyoid ligament.
Extracranial internal carotid artery aneurysm presenting as symptomatic hypoglossal and glossopharyngeal nerve paralysis.
Fluid-fluid levels in intracranial schwannomas.
[A case of zoster sine herpete with involvement of the unilateral IX, X and XI cranial and upper cervical nerves].
Microvascular decompression in the treatment of hypertension: review and update.
Cranial nerve vascular compression syndromes of the trigeminal, facial and vago-glossopharyngeal nerves: comparative anatomical study of the central myelin portion and transitional zone; correlations with incidences of corresponding hyperactive dysfunc...
Jefferson fracture resulting in Collet-Sicard syndrome.
Glossopharyngeal neuralgia with asystole and seizures.
Medical management of trigeminal neuropathic pains.
Microvascular decompression for treatment of trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia: three surgical approach variations: technical note.
GLOSSOPHARYNGEAL NEURALGIA ASSOCIATED WITH BRADYCARDIA, SYNCOPE, AND SEIZURES.
Epidemiology of typical and atypical craniofacial neuralgias.
A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions.
Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes.
Current status of infraclavicular subclavian vein catheterization.
Vascular erosion by central venous catheters. Clinical features and outcome.
Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.
Spontaneous bacterial empyema in cirrhotic patients: a prospective study.
Hepatic hydrothorax. Cause and management.
Hepatic hydrothorax: pathogenesis, diagnosis, and management.
Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management.
Fumonisin-induced pulmonary edema and hydrothorax in swine.
Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.
TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
Fibroma of the ovary with ascites and hydrothorax; Meigs' syndrome.
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting.
Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites.
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.
Transjugular intrahepatic portosystemic shunt: current status.
The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.
Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient.
Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme.
Hepatitis C and renal disease: an update.
Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas.
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia.
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.
Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin.
CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.
Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies.
Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations.
GB virus type C: a beneficial infection?
The complement system in systemic autoimmune disease.
GB virus type C infection modulates T-cell activation independently of HIV-1 viral load.
NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases.
Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia.
GB virus type C interactions with HIV: the role of envelope glycoproteins.
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences.
Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
Regulation of CC chemokine receptor 5 in hepatitis G virus infection.
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.
An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells.
Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.
Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice.
Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia.
Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees.
GB virus C replicates in primary T and B lymphocytes.
GB virus type C/Hepatitis G virus.
A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission.
A role for hepatitis C virus infection in type II cryoglobulinemia.
Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae.
Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Persistent GB virus C infection and survival in HIV-infected men.
Flavivirus susceptibility in Aedes aegypti.
Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.
Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.
A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
Lower Extremity Cellulitis, Weight Gain, pain
Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis.
Multidisciplinary management of Hunter syndrome.
Impact of infectious burden on extent and long-term prognosis of atherosclerosis.
Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report.
The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation.
Estimating foodborne gastroenteritis, Australia.
Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome.
Broad RNA interference-mediated antiviral immunity and virus-specific inducible responses in Drosophila.
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy.
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery.
Functional analysis of Avr9/Cf-9 rapidly elicited genes identifies a protein kinase, ACIK1, that is essential for full Cf-9-dependent disease resistance in tomato.
A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome).
Family Iridoviridae: poor viral relations no longer.
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.
Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.
The role of the cytoskeleton during viral infection.
The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase.
Incidence of the mucopolysaccharidoses in Northern Ireland.
SUMO: of branched proteins and nuclear bodies.
Acyclic nucleoside phosphonates: a key class of antiviral drugs.
Hybrid necrosis: autoimmunity as a potential gene-flow barrier in plant species.
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
Viruses and microRNAs: RISCy interactions with serious consequences.
Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo.
RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2.
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.